相关实验视频

Updated: Jul 15, 2025

Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits

Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits

Published on: March 16, 2016

蛋白质限制减缓了老鼠阿尔茨海默病的发展和进展

Reji Babygirija^1,2,3, Michelle M Sonsalla^1,2,4, Jericha Mill⁵

¹Department of Medicine, University of Wisconsin-Madison, Madison, WI, USA.

Research square

|October 4, 2023

概括

饮食中蛋白质限制 (PR) 有利于代谢健康,并减缓老鼠阿尔茨海默病 (AD) 的进展. 这种干预改善了认知,延长了寿命,并减少了AD病理,这表明了潜在的治疗应用.

科学领域:

营养神经科学营养神经科学
代谢调节代谢调节代谢调节代谢调节
神经退行性疾病研究研究

背景情况:

饮食中的蛋白质是代谢健康和衰老的关键因素.
众所周知,蛋白质限制 (PR) 在动物模型中可以延长寿命和健康期.
阿尔茨海默病 (AD) 是一种进展性神经退行性疾病,治疗选择有限.

结论:

饮食中蛋白质的限制显示出显著的代谢益处,并减缓了阿尔茨海默病的进展.
在AD的小鼠模型中,PR影响分子通路 (mTORC1,自) 并保持认知功能.
PR或模仿其效果可能为阿尔茨海默病提供一个有前途的治疗策略.

关键词:

3xTgg 3xTg 3xTg 3xTg 3xTg 3xTg 3x 阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.自自是自的过程.在 mTORC1 的情况下,mTORC1 是蛋白质限制蛋白质限制

更多相关视频

Assessing Activity-based Anorexia in Mice

Assessing Activity-based Anorexia in Mice

Published on: May 14, 2018

A Technique for Serial Collection of Cerebrospinal Fluid from the Cisterna Magna in Mouse

A Technique for Serial Collection of Cerebrospinal Fluid from the Cisterna Magna in Mouse

Published on: November 10, 2008

相关概念视频

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...